175 related articles for article (PubMed ID: 22410201)
1. One-year clinical and radiological evolution of a patient with refractory Takayasu's arteritis under treatment with tocilizumab.
Bredemeier M; Rocha CM; Barbosa MV; Pitrez EH
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S98-100. PubMed ID: 22410201
[TBL] [Abstract][Full Text] [Related]
2. Rescue treatment with tocilizumab for Takayasu arteritis resistant to TNF-α blockers.
Salvarani C; Magnani L; Catanoso MG; Pipitone N; Versari A; Dardani L; Pulsatelli L; Meliconi R; Boiardi L
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S90-3. PubMed ID: 22410150
[TBL] [Abstract][Full Text] [Related]
3. Successful tocilizumab treatment in a child with refractory Takayasu arteritis.
Bravo Mancheño B; Perin F; Guez Vázquez Del Rey Mdel M; García Sánchez A; Alcázar Romero PP
Pediatrics; 2012 Dec; 130(6):e1720-4. PubMed ID: 23147976
[TBL] [Abstract][Full Text] [Related]
4. Rapid control of disease activity by tocilizumab in 10 'difficult-to-treat' cases of Takayasu arteritis.
Goel R; Danda D; Kumar S; Joseph G
Int J Rheum Dis; 2013 Dec; 16(6):754-61. PubMed ID: 24382284
[TBL] [Abstract][Full Text] [Related]
5. Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-α and IL-6 receptor targeted therapies in refractory Takayasu arteritis.
Youngstein T; Peters JE; Hamdulay SS; Mewar D; Price-Forbes A; Lloyd M; Jeffery R; Kinderlerer AR; Mason JC
Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S11-8. PubMed ID: 24093733
[TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with more severe Takayasu's arteritis.
Sun Y; Ma L; Ma L; Kong X; Chen H; Lv P; Lin J; Liu H; Yan Y; Ji Z; Yang C; Dai S; Wan W; Zou Y; Jin X; Jiang L
Rheumatol Int; 2017 Dec; 37(12):2019-2026. PubMed ID: 29030659
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy and improvement of health-related quality of life in patients with Takayasu's arteritis treated with infliximab.
Quartuccio L; Schiavon F; Zuliani F; Carraro V; Catarsi E; Tavoni AG; Bombardieri S; Punzi L; De Vita S
Clin Exp Rheumatol; 2012; 30(6):922-8. PubMed ID: 23044074
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor alpha inhibitors in patients with Takayasu's arteritis refractory to standard immunosuppressive treatment: cases series and review of the literature.
Novikov PI; Smitienko IO; Moiseev SV
Clin Rheumatol; 2013 Dec; 32(12):1827-32. PubMed ID: 23995735
[TBL] [Abstract][Full Text] [Related]
9. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients.
Mekinian A; Comarmond C; Resche-Rigon M; Mirault T; Kahn JE; Lambert M; Sibilia J; Néel A; Cohen P; Hie M; Berthier S; Marie I; Lavigne C; Anne Vandenhende M; Muller G; Amoura Z; Devilliers H; Abad S; Hamidou M; Guillevin L; Dhote R; Godeau B; Messas E; Cacoub P; Fain O; Saadoun D;
Circulation; 2015 Nov; 132(18):1693-700. PubMed ID: 26354797
[TBL] [Abstract][Full Text] [Related]
11. Refractory Takayasu's arteritis successfully treated with the human, monoclonal anti-tumor necrosis factor antibody adalimumab.
Tatò F; Rieger J; Hoffmann U
Int Angiol; 2005 Sep; 24(3):304-7. PubMed ID: 16158044
[TBL] [Abstract][Full Text] [Related]
12. The management of Takayasu's arteritis: personal experience.
de Franciscis S; Serra R; Luongo A; Sabino G; Puzziello A
Ann Vasc Surg; 2007 Nov; 21(6):754-60. PubMed ID: 17512164
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil in Takayasu's arteritis.
Goel R; Danda D; Mathew J; Edwin N
Clin Rheumatol; 2010 Mar; 29(3):329-32. PubMed ID: 20054700
[TBL] [Abstract][Full Text] [Related]
14. Tocilizumab for Treating Takayasu's Arteritis and Associated Stroke: A Case Series and Updated Review of the Literature.
Osman M; Emery D; Yacyshyn E
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1291-8. PubMed ID: 25869777
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of tocilizumab for the treatment of Chinese Takayasu's arteritis.
Zhou J; Chen Z; Li J; Yang Y; Zhao J; Chen H; Liu M; Sun F; Li M; Tian X; Zeng X
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):171-175. PubMed ID: 28406764
[TBL] [Abstract][Full Text] [Related]
16. Low-dose methotrexate as a steroid-sparing agent in a child with Takayasu's arteritis.
Shetty AK; Stopa AR; Gedalia A
Clin Exp Rheumatol; 1998; 16(3):335-6. PubMed ID: 9631760
[TBL] [Abstract][Full Text] [Related]
17. Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis.
Valsakumar AK; Valappil UC; Jorapur V; Garg N; Nityanand S; Sinha N
J Rheumatol; 2003 Aug; 30(8):1793-8. PubMed ID: 12913937
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis.
Lo Gullo A; Mandraffino G; Aragona CO; Molica Colella A; Saitta A; Imbalzano E
Reumatismo; 2017 Dec; 69(4):184-188. PubMed ID: 29320845
[TBL] [Abstract][Full Text] [Related]
19. Takayasu's arteritis identified by computerized tomography: revealing the submerged portion of the iceberg?
Zlatkin S; Aamar S; Specter G; Leibowitz D; Simanovsky N; Yeshurun D; Heyman SN
Isr Med Assoc J; 1999 Dec; 1(4):245-9. PubMed ID: 10731353
[TBL] [Abstract][Full Text] [Related]
20. Induction of remission in a patient with Takayasu's arteritis by low dose pulses of methotrexate.
Mevorach D; Leibowitz G; Brezis M; Raz E
Ann Rheum Dis; 1992 Jul; 51(7):904-5. PubMed ID: 1352962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
